Notable Labs, Ltd. (NTBLQ)

Market Cap	10.00 -100.0%
Revenue (ttm)	313.00K +3,812.5%
Net Income	-10.54M
EPS	-1.42
Shares Out	9.66M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	5
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	29.99
RSI	28.52
Earnings Date	n/a

About Notable Labs

Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive medicines for patients with cancer. The company, through its proprietary Predictive Medicines Platform (PMP), bio-simulates a patient’s cancer treatment and predicts whether patient will clinically respond to their actual treatment. Its PMP is designed to identify and select patients expected to be clinically responsive prior to the initiation of their treatment and enable fast-track therapeutic development in this patient population. The company’s lead prod...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2014
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: NTBLQ

Financial Performance

In 2023, Notable Labs's revenue was $310,000, an increase of 3775.00% compared to the previous year's $8,000. Losses were -$11.26 million, -21.82% less than in 2022.